NeoGenomics Laboratories

In News

Fort Myers-based cancer lab expects strong performance in 2025, with new CEO - The News-Press

The News-Press - Jan 16, 2025

Fort Myers-based NeoGenomics acquires New Jersey lab - Gulfshore Business

Gulfshore Business - Mar 10, 2025

NeoGenomics to Report First Quarter 2025 Financial Results on April 29, 2025 - Business Wire

Business Wire - Apr 08, 2025

Lindsey Gasparini: New FDA-approved therapy targets Claudin18.2 in gastric cancers - Oncodaily

Oncodaily - Nov 03, 2024

NeoGenomics Announces PanTracer Tissue and PanTracer Tissue + HRD Now Available to Support More Informed and Timely Cancer Care - Yahoo Finance

Yahoo Finance - Jun 30, 2025

Here’s Why NeoGenomics (NEO) Sold Off in Q1 - Insider Monkey

Insider Monkey - Jul 02, 2025

NeoGenomics expands with Pathline acquisition - Investing.com

Investing.com - Mar 10, 2025

NeoGenomics and Ultima Genomics collaborate to expand clinical test offerings in Oncology using the UG 100 sequencing platform - PR Newswire

PR Newswire - Apr 29, 2025

Adaptive Biotechnologies and NeoGenomics Partner to Expand - GlobeNewswire

GlobeNewswire - Jan 14, 2025

NeoGenomics Announces Chief Executive Officer Appointment - ACCESS Newswire

ACCESS Newswire - Jul 03, 2025

Understanding Preliminary Injunction: A Review of a Recent Federal Circuit Decision - JD Supra

JD Supra - Sep 17, 2024

Natera Expands Patent Battle: Adds New Patent to Lawsuit Against NeoGenomics' Cancer Test - Stock Titan

Stock Titan - Dec 17, 2024

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.